跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIO-GABAPENTIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIO-GABAPENTIN
Authorized
STANDARD
BIO-GABAPENTIN
biomed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d33a192ff2af22c2
Company
biomed pharma
Type
Standard
Approval Details
Approval Id
d33a192ff2af22c2
Drug Approval Canada Name
BIO-GABAPENTIN
Product Name
BIO-GABAPENTIN
Status
Cancelled Post Market
Status Date
2022-02-02
Original Market Date
2019-07-17
Din
02450194
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N02BF01 GABAPENTIN
Atc Name
n 02 bf 01
Aig Number
0125929005
Company Name
biomed pharma
Company Address
1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8
Active Ingredients
GABAPENTIN
800 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d33a192ff2af22c2
Type
Standard
Back to Health Canada Approvals